Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
14.51
+1.03 (7.64%)
At close: Apr 8, 2026, 4:00 PM EDT
14.58
+0.07 (0.48%)
After-hours: Apr 8, 2026, 5:57 PM EDT
Relay Therapeutics Market Cap
Relay Therapeutics has a market cap or net worth of $2.59 billion as of April 8, 2026. Its market cap has increased by 399.93% in one year.
Market Cap
2.59B
Enterprise Value
2.02B
1-Year Change
399.93%
Ranking
Category
Stock Price
$14.51
Market Cap Chart
Since July 16, 2020, Relay Therapeutics's market cap has decreased from $3.03B to $2.59B, a decrease of -14.55%. That is a compound annual growth rate of -2.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 2.41B | 64.31% |
| Dec 31, 2025 | 1.47B | 112.63% |
| Dec 31, 2024 | 689.62M | -49.19% |
| Dec 29, 2023 | 1.36B | -24.86% |
| Dec 30, 2022 | 1.81B | -45.57% |
| Dec 31, 2021 | 3.32B | -11.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Soleno Therapeutics | 2.71B |
| IDEAYA Biosciences | 2.70B |
| Enliven Therapeutics | 2.59B |
| Kodiak Sciences | 2.58B |
| Disc Medicine | 2.53B |
| Beam Therapeutics | 2.48B |
| Celldex Therapeutics | 2.48B |
| Immunome | 2.47B |